SCHEMBL6500347

SCHEMBL6500347

Oc1ccccc1N=C(c1ccccc1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.52
KDM4E B2RXH2 4/20 0.52
NPC1 O15118 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
LMNA P02545 3/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
HTT P42858 2/20 0.52
ESR2 Q92731 7/20 0.50
ESR1 P03372 6/20 0.50
GAA P10253 4/20 0.47
RAB9A P51151 3/20 0.39
ALDH1A1 P00352 3/20 0.39
POLB P06746 3/20 0.39
CA12 O43570 2/20 0.39
CA2 P00918 2/20 0.39
HPGD P15428 2/20 0.39
BLM P54132 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CYP3A4 P08684 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28549425 0.79 ESR2 (0.51) MAPTNPC1MEN1KMT2AESR2
SCHEMBL13209060 0.76 GAA (0.50) MAPTNPC1SMN1; SMN2MEN1KMT2A
SCHEMBL15188908 0.76 GAA (0.46) MEN1KMT2AESR2ESR1GAA
SCHEMBL29220708 0.76 GAA (0.46) MAPTKDM4ENPC1SMN1; SMN2LMNA
SCHEMBL2784971 0.76 GAA (0.46) NPC1SMN1; SMN2MEN1KMT2AESR2
SCHEMBL15275530 0.76 ESR2 (0.75) MEN1KMT2AESR2ESR1GAA
SCHEMBL13967956 0.76 GAA (0.46) MAPTNPC1SMN1; SMN2LMNAMEN1
SCHEMBL6547698 0.76 ESR1 (0.75) MAPTNPC1SMN1; SMN2LMNAESR2
SCHEMBL11494065 0.75 SMN1; SMN2 (0.45) MAPTKDM4ENPC1SMN1; SMN2LMNA
SCHEMBL18489521 0.75 IDO1 (0.50) MAPTKDM4ENPC1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1234693-C Indazol compound for inhibiting protein kinase and medicine composition and their application AGOURON PHARMA (US) 2006-01-04 CN disclosed
US-6884890-B2 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use AGOURON PHARMACEUTICALS, INC. (US) 2005-04-26 US disclosed
CN-1495171-A Indazol compound for inhibiting protein kinase and medicine composition and their application ������ҩ�����޹�˾ 2004-05-12 CN disclosed
CN-1137884-C Indazole compounds and pharmaceutical compositions that inhibit protein kinases and methods of use thereof ������ҩ�����޹�˾ 2004-02-11 CN disclosed
CN-1374950-A Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and their use AGOURON PHARMACETUICALS INC (US) 2002-10-16 CN disclosed